Prognostic value of chronic kidney disease after transcatheter aortic valve implantation M Yamamoto, K Hayashida, G Mouillet, T Hovasse, B Chevalier, A Oguri, ... Journal of the American College of Cardiology 62 (10), 869-877, 2013 | 182 | 2013 |
Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 … A Oguri, M Yamamoto, G Mouillet, M Gilard, M Laskar, H Eltchaninoff, ... Circulation: Cardiovascular Interventions 7 (4), 602-610, 2014 | 164 | 2014 |
Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry M Gilard, H Eltchaninoff, P Donzeau-Gouge, K Chevreul, J Fajadet, ... Journal of the American College of Cardiology 68 (15), 1637-1647, 2016 | 151 | 2016 |
Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation M Yamamoto, K Meguro, G Mouillet, E Bergoend, JL Monin, P Lim, ... The American journal of cardiology 111 (1), 94-99, 2013 | 148 | 2013 |
Renal function–based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation M Yamamoto, K Hayashida, G Mouillet, B Chevalier, K Meguro, ... JACC: Cardiovascular Interventions 6 (5), 479-486, 2013 | 144 | 2013 |
Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 … R Chopard, E Teiger, N Meneveau, S Chocron, M Gilard, M Laskar, ... Cardiovascular Interventions 8 (10), 1346-1355, 2015 | 129 | 2015 |
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial J Silvain, B Lattuca, F Beygui, G Rangé, Z Motovska, JG Dillinger, ... The Lancet 396 (10264), 1737-1744, 2020 | 106 | 2020 |
Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry. A Oguri, M Yamamoto, G Mouillet, M Gilard, M Laskar, H Eltchaninoff, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2015 | 82 | 2015 |
Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve® devices: Results from the FRANCE 2 Registry G Mouillet, N Lellouche, M Yamamoto, A Oguri, JL Dubois‐Rande, ... Catheterization and Cardiovascular Interventions 86 (3), E158-E166, 2015 | 77 | 2015 |
Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged≥ 90 years versus< 90 years M Yamamoto, K Meguro, G Mouillet, E Bergoend, JL Monin, P Lim, ... The American journal of cardiology 110 (8), 1156-1163, 2012 | 76 | 2012 |
Peridevice leak after left atrial appendage closure: incidence, risk factors, and clinical impact A Nguyen, R Gallet, E Riant, JF Deux, M Boukantar, G Mouillet, ... Canadian Journal of Cardiology 35 (4), 405-412, 2019 | 74 | 2019 |
Effect of body mass index on 30-and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 … M Yamamoto, G Mouillet, A Oguri, M Gilard, M Laskar, H Eltchaninoff, ... The American journal of cardiology 112 (12), 1932-1937, 2013 | 73 | 2013 |
Coronary procedures after TAVI with the self‐expanding aortic bioprosthesis Medtronic CoreValve™, not an easy matter M Boukantar, R Gallet, G Mouillet, A Belarbi, V Rubimbura, J Ternacle, ... Journal of Interventional Cardiology 30 (1), 56-62, 2017 | 60 | 2017 |
Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry M Yamamoto, G Mouillet, K Meguro, M Gilard, M Laskar, H Eltchaninoff, ... The Annals of thoracic surgery 97 (1), 29-36, 2014 | 55 | 2014 |
Patients without prolonged QRS after TAVI with CoreValve device do not experience high‐degree atrio‐ventricular block G Mouillet, N Lellouche, P Lim, K Meguro, M Yamamoto, JF Deux, ... Catheterization and Cardiovascular Interventions 81 (5), 882-887, 2013 | 53 | 2013 |
Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences R Gallet, A Seemann, M Yamamoto, D Hayat, G Mouillet, JL Monin, ... The American journal of cardiology 111 (11), 1619-1624, 2013 | 50 | 2013 |
Effect of body mass index< 20 kg/m2 on events in patients who underwent transcatheter aortic valve replacement M Yamamoto, K Hayashida, Y Watanabe, G Mouillet, T Hovasse, ... The American journal of cardiology 115 (2), 227-233, 2015 | 31 | 2015 |
Outcomes and safety of same‐day discharge after percutaneous coronary intervention: A 10‐year single‐center study V Rubimbura, L Rostain, A Duval, S Akakpo, M Boukantar, P Boiron, ... Catheterization and Cardiovascular Interventions 94 (1), 105-111, 2019 | 27 | 2019 |
Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve K Meguro, N Lellouche, M Yamamoto, E Fougeres, JL Monin, P Lim, ... The American Journal of Cardiology 111 (12), 1778-1783, 2013 | 27 | 2013 |
FRANCE 2 Registry investigators. Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry A Oguri, M Yamamoto, G Mouillet, M Gilard, M Laskar, H Eltchaninoff, ... EuroIntervention 10 (9), e1-e9, 2015 | 20 | 2015 |